Xiaobin Wu Sells $106K of BeOne Medicines Ltd (ONC) — SEC Form 4, Aug 27, 2026
Open-Market Net Sale · SEC Form 4
−$106,400
10b5-1 Plan
Equity position changed by 0.0%
Equity Position
1.29M sh
1,286,729 → 1,286,449
Equity Change
0.0%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Xiaobin Wu CIK 0001739452 |
COO
|
Xiaobin Wu at BeOne Medicines Ltd
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$8,753,697
More from this insider at BeOne Medicines Ltd
| 2026-06-25 | Sell | -$356,927 | View |
| 2026-06-18 | Sell | -$361,997 | View |
| 2026-06-15 | Sell | -$163,512 | View |
| 2026-06-10 | Sell | -$399,738 | View |
| 2026-03-11 | Award | — | View |
Non-Derivative Securities Transactions
Footnotes (2)
Related filings at BeOne Medicines Ltd
Institutional Holders
13F holders · Jun 30, 2026
284
institutional managers reporting a position
Largest by reported value
- Baker Bros. Advisors Lp $2.51B
- Primecap Management Co/Ca/ $1.43B
- Capital International Investors $1.2B
5%+ Holders · 13D/G
2 filers
-
Hhlr Advisors, Ltd. 4.9%
Other insiders at BeOne Medicines Ltd
-
Titus B. Ball -$632K
-
Chan Henry Lee -$447K
-
Xiaodong Wang -$11.3M
-
Xiaodong Wang -$10.9M
-
Chan Henry Lee -$418K
GET /v1/forms/4/0001739452-26-000011
API docs
View Original SEC Filing